EnCompass Technologies announced today that it received FDA investigational device exemption for its F2 cerebral embolic […]
PercAssist announced today that it successfully completed the first patient treatment in its EUREKA first-in-human […]
Carlsmed recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device […]